Rocket One Inc.

RKTO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-12.5M $-8.2M $-8.1M $-11.4M $-14.3M $-7.2M $-7.7M $-2.5M
Depreciation & Amortization
Depreciation $1.0K $1.2K $1.2K
Amortization
Stock-Based Compensation $1.2M $804.3K $216.4K $620.8K $1.3M $737.7K $2.5M $143.1K
Net Cash from Operating Activities $-9.8M $-7.0M $-8.4M $-9.3M $-12.1M $-6.1M $-4.9M $-2.1M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $-300.0K $1.2M $-165.4K $-1.8M $-895.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $9.3M $4.7M $11.3M $6.0M $18.2M $8.7M $7.5M $1.2M
Net Change in Cash $-2.1M $5.9M $754.2K $1.6M $-947.8K
Free Cash Flow